Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

NCT: NCT06139016 · COMPLETED

NCT IDNCT06139016
StatusCOMPLETED
Start Date2024-07-11
Completion2024-11-27
SponsorYale University (OTHER)
First posted
Last updated

Brief Summary

Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and assessing whether these tools can improve the tolerability and effectiveness of treatment with ketamine/esketamine

Frequently Asked Questions

What is Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment?

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment is a clinical trial registered under NCT06139016. Current status: COMPLETED.

What is the status of NCT06139016?

The current status of NCT06139016 (Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment) is: COMPLETED.

When did Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment start?

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment started on 2024-07-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.